中国高危家庭乳腺癌易感基因的突变筛查：研究结果将推动中国的基因检测策略发展。 - Suppr

Suppr

超能文献

Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China.

作者信息

Cao A-Yong, Hu Zhen, Shao Zhi-Ming

出版信息

Breast Cancer Res Treat. 2010 Feb;120(1):271-2. doi: 10.1007/s10549-009-0598-4. Epub 2009 Oct 24.

DOI:10.1007/s10549-009-0598-4

PMID:19856097

Abstract

摘要

相似文献

Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China.中国高危家庭乳腺癌易感基因的突变筛查：研究结果将推动中国的基因检测策略发展。

Breast Cancer Res Treat. 2010 Feb;120(1):271-2. doi: 10.1007/s10549-009-0598-4. Epub 2009 Oct 24.

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。

Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.

Genetic predisposition to breast cancer: past, present, and future.乳腺癌的遗传易感性：过去、现在与未来。

Annu Rev Genomics Hum Genet. 2008;9:321-45. doi: 10.1146/annurev.genom.9.081307.164339.

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.癌症易感性检测panel 基因与乳腺癌的相关性研究。

JAMA Oncol. 2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424.

Translational advances regarding hereditary breast cancer syndromes.遗传性乳腺癌综合征的转化研究进展。

J Surg Oncol. 2012 Apr 1;105(5):444-51. doi: 10.1002/jso.21856.

Ten genes for inherited breast cancer.十个遗传性乳腺癌相关基因。

Cancer Cell. 2007 Feb;11(2):103-5. doi: 10.1016/j.ccr.2007.01.010.

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.一项对超过35000名乳腺癌女性进行的研究，采用了一个包含25个遗传性癌症基因的基因检测面板进行检测。

Cancer. 2017 May 15;123(10):1721-1730. doi: 10.1002/cncr.30498. Epub 2017 Jan 13.

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?所谓的低外显率乳腺癌基因，如ATM、BRIP1、PALB2和CHEK2，对于有强烈家族病史的女性来说是高风险因素吗？

Breast Cancer Res. 2008;10(3):208. doi: 10.1186/bcr2099. Epub 2008 Jun 5.

Hereditary breast cancer: new genetic developments, new therapeutic avenues.遗传性乳腺癌：新的基因进展，新的治疗途径。

Hum Genet. 2008 Aug;124(1):31-42. doi: 10.1007/s00439-008-0529-1. Epub 2008 Jun 25.

Growing recognition of the role for rare missense substitutions in breast cancer susceptibility.对罕见错义替换在乳腺癌易感性中作用的认识不断增加。

Biomark Med. 2014;8(4):589-603. doi: 10.2217/bmm.13.143.

引用本文的文献

A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.在中国高风险乳腺癌患者中发现的 CHEK2 Y390C 突变是一种新型的反复出现的突变，它削弱了 CHEK2 的活性，并与乳腺癌风险的增加相关。

Oncogene. 2015 Oct 1;34(40):5198-205. doi: 10.1038/onc.2014.443. Epub 2015 Jan 26.

The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China.中国新疆多民族地区三阴性乳腺癌患者 BRCA1/2 突变的流行率。

Eur J Med Res. 2014 Jun 25;19(1):35. doi: 10.1186/2047-783X-19-35.

Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China.中国西北地区多民族地区乳腺癌女性中 BRCA1 和 BRCA2 种系突变的流行率。

J Breast Cancer. 2013 Mar;16(1):50-4. doi: 10.4048/jbc.2013.16.1.50. Epub 2013 Mar 31.

Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes.乳腺癌和/或卵巢癌家族史对乳腺癌预后的影响。

Exp Ther Med. 2011 Sep;2(5):917-923. doi: 10.3892/etm.2011.275. Epub 2011 May 26.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验